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Endoscopic Assessment of the Duodenum in Dogs with Inflammatory
Bowel Disease
Abstract
Background: Endoscopy is performed for direct inspection of the mucosa and acquisition of biopsies in dogs
with inflammatory bowel disease (IBD). Aim: To evaluate the interobserver agreement in the endoscopic
assessment of duodenal mucosa in dogs with IBD. Methods: Thirty-five archived endoscopic images of grossly
normal (n = 6) and inflamed (n = 29) duodenal mucosa were displayed to 3 expert and 5 trainee endoscopists.
Each image was assessed independently by endoscopists for mucosal abnormalities using established indices
(of hyperemia, granularity, friability, lymphatic dilatation, and erosions) or interpreted as normal mucosa
(trial 1). A repeated trial (trial 2) was performed with the same images presented in random order 1 month
later, and accompanied by a visual template. Results: There was slight interobserver agreement in initial
mucosal assessment for expert and trainee endoscopists in trial 1 (kappa ≤ 0.02, P > .05). Interobserver
agreement improved in trial 2 for both expert and trainee endoscopists (kappa = 0.2, P > .05) for experts and
(P < .05) for trainees. There was a significant (P < .01) improvement in trainee endoscopy scores of lesions
from trial 1 to trial 2. Regression analysis showed a significant (P < .01) difference between expert versus
trainee endoscopy scores in trial 1. Repeat lesion assessment aided by use of a visual template (trial 2)
improved the overall scores of trainee endoscopists to near that of expert endoscopists (P = .06). Conclusions
and Clinical Importance: Interobserver agreement of IBD mucosal appearance from endoscopic findings
benefitted from operator experience.
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Background: Endoscopy is performed for direct inspection of the mucosa and acquisition of biopsies in dogs with
inﬂammatory bowel disease (IBD).
Aim: To evaluate the interobserver agreement in the endoscopic assessment of duodenal mucosa in dogs with IBD.
Methods: Thirty-ﬁve archived endoscopic images of grossly normal (n = 6) and inﬂamed (n = 29) duodenal mucosa
were displayed to 3 expert and 5 trainee endoscopists. Each image was assessed independently by endoscopists for mucosal
abnormalities using established indices (of hyperemia, granularity, friability, lymphatic dilatation, and erosions) or inter-
preted as normal mucosa (trial 1). A repeated trial (trial 2) was performed with the same images presented in random
order 1 month later, and accompanied by a visual template.
Results: There was slight interobserver agreement in initial mucosal assessment for expert and trainee endoscopists in
trial 1 (kappa ≤ 0.02, P > .05). Interobserver agreement improved in trial 2 for both expert and trainee endoscopists
(kappa = 0.2, P > .05) for experts and (P < .05) for trainees. There was a signiﬁcant (P < .01) improvement in trainee
endoscopy scores of lesions from trial 1 to trial 2. Regression analysis showed a signiﬁcant (P < .01) diﬀerence between
expert versus trainee endoscopy scores in trial 1. Repeat lesion assessment aided by use of a visual template (trial 2)
improved the overall scores of trainee endoscopists to near that of expert endoscopists (P = .06).
Conclusions and Clinical Importance: Interobserver agreement of IBD mucosal appearance from endoscopic ﬁndings
beneﬁtted from operator experience.
Key words: Endoscopy; Inﬂammatory bowel disease; Mucosal assessment.
Diﬀerent indices have been proposed to measurethe activity, severity, or both of inﬂammatory
bowel disease (IBD) in dogs to evaluate eﬃcacy of
treatment in clinical trials.1–3 All of these indices are
based on clinical signs, biologic data, or both. Gastro-
intestinal (GI) endoscopy is a well-established tech-
nique to directly visualize the mucosa and acquire
targeted biopsy specimens for histopathologic exami-
nation. Previously, abnormal endoscopic mucosal
observations in dogs with signs of chronic GI have
been associated with detectable histopathologic lesions,
including inﬂammatory and neoplastic disorders.4 As
endoscopy is routinely performed for diagnosis of IBD
in dogs, endoscopic ﬁndings could be used to measure
disease activity.
Several endoscopic indices for evaluation of inﬂam-
matory activity in IBD in humans (ie, Crohn’s disease
[CD]5,6 and ulcerative colitis [UC]7–10) have been
designed. All of these scoring systems were based on
the severity/extent of mucosal granularity, vascular
pattern, vulnerability of mucosa, and mucosal damage
(mucus, ﬁbrin, exudates, erosions, and ulcer) observed
during colonoscopy. However, no standardized model
has been established. Separate studies in dogs with
small intestinal IBD have yielded conﬂicting results on
the utility of endoscopic scoring as a measure of dis-
ease activity.1,11 One potential reason for this discrep-
ancy could be interobserver variation in identifying
endoscopic abnormalities based on operator experience
and the lack of systematic endoscopic assessment. The
aim of this study was to evaluate the interobserver
agreement in the assessment of duodenal appearance
in dogs with IBD.
Materials and Methods
Selection of Images
Two hundred archived endoscopic images from consecutive
duodenoscopy procedures performed in dogs with IBD between
2004 and 2012 at Iowa State University were retrieved from a
computerized database and reviewed. A total of 35 endoscopic
images of grossly normal (some images obtained after biopsy)
and inﬂamed duodenal mucosa from 25 IBD dogs were selected
based on the authors’ experience of characteristic lesions, for
study enrollment. Image selection was determined by joint
agreement of authors JES and AEJ. A diagnosis of IBD was
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based on previously established clinicopathologic and histopatho-
logic criteria.1,2,11–13 Endoscopic interpretation of intestinal lym-
phangiectasia included observation of multifocal to diﬀuse white
foci within the mucosa suggestive of lymphatic distension.16 Duo-
denoscopy procedures were performed with a commercial video
endoscope (Olympus GIF-160)a with still images of normal and
abnormal mucosa captured by the endoscopist. The ﬁle size of
the down-loaded images was approximately 100 kb, with a pixel
array of 640 9 480 and 24-bit color. These still images were then
arranged in a Powerpointb presentation for testing purposes.
Assessment of Images
Endoscopic still images in Powerpointb format were assessed
by 3 expert and 5 trainee endoscopists (none were JES or AEJ),
for inﬂammatory activity. Expert endoscopists were deﬁned as
individuals with advanced clinical training and active and consis-
tent operator participation in a minimum of 50 GI endoscopy
procedures over the preceding 24 months. The experts were expe-
rienced and familiar with mucosal lesions as identiﬁed with GI
endoscopy. Trainee endoscopists had minimal endoscopic train-
ing and lacked consistent endoscopic operator experience with
participation in less than 5 procedures over the same 24-month
period.
The selected images were randomized by means of a Research
report randomizerc program and assessed independently by each
endoscopist for mucosal appearance. Neither the clinical data
nor the date on which the image was taken was made known to
the endoscopists. The endoscopic variables evaluated included
hyperemia, erosions, granularity, friability, lymphatic dilatation,
or the mucosal appearance was interpreted as normal (Table 1).
Written deﬁnitions of each variable were made available to all
endoscopists. If an individual image contained more than 1
mucosal abnormality, the endoscopist was asked to identify the
salient lesion (trial 1). Each endoscopist had 2 weeks to complete
the trial. The assessment of mucosal appearance was repeated
1 month after the ﬁrst assessment (trial 2), although the endosco-
pists were not informed that they were going to assess the same
images (order rerandomized) a second time. In addition, each en-
doscopist was instructed to review a template of representative
mucosal appearances (Fig 1) before image reassessment (trial 2)
to see whether this exercise improved endoscopy scores.
Analysis of Data
Data were collected from each operator using predesigned
Exceld spread sheets for statistical analysis. Fleiss kappa coeﬃ-
cients were calculated to assess agreement among multiple raters
within expert and trainee groups and tested against null value
0 by using the “irr” package in R.e Fleiss kappa interpretation
is similar to that of Cohen’s kappa. A mixed-eﬀects logistic
regression model was used to analyze descriptive appearance
agreement with gold standard for comparison of assessment
accuracy by the Glimmix procedure in SAS. Group (trainee ver-
sus expert), trial, and their interaction were the ﬁxed eﬀects in
model, whereas endoscopist was the random eﬀect. A P value
<.05 was considered statistically signiﬁcant.
Results
The aﬀected dogs were predominantly middle-aged
(age range 1–11 years) mean age of 6.8 years, exhib-
ited chronic gastrointestinal signs (4.8 month dura-
tion), CIBDAI score of 5.9, and had a histologic
biopsy grade of mild IBD 24% and moderate-severe
IBD 76%. There were 11 spayed females and 14 neu-
tered males included in the study. Dogs with IBD
included: 4 West Highland White Terriers, 3 Golden
Retrievers, 2 mixed breed dogs, 2 Boxers, 2 Labrador
Retrievers, 2 Shih Tzus, 2 Yorkshire terriers, and 1
each of Wheaton Terrier, German Shepherd dog, Vis-
zla, English Bulldog, Cocker Spaniel, Gordon Setter,
Beagle, and Miniature Poodle. None of the dogs had
evidence of inﬂammation in other body systems, based
on results obtained from diagnostic testing, and each
dog had failed to respond fully to previous dietary and
antibiotic interventions.
Among the 35 images of the test set obtained during
duodenoscopic examination in dogs with IBD, 6 were
of grossly normal mucosa (some images obtained post-
biopsy), 6 friable, 5 hyperemic, 6 increased granularity,
7 erosions, and 5 lymphatic dilatation. All endoscopic
images of abnormal mucosal appearances were associ-
ated with histologically inﬂamed mucosa of varying
severity. The mucosal appearance of lymphatic dilata-
tion was associated with variable distention of the su-
pravillus, subvillus, or both lymphatic vessels
microscopically in all 5 dogs. Of the 6 normal endo-
scopic images, 1 dog had no abnormalities observed
on histopathologic examination of tissue samples,
whereas biopsy specimens obtained from the other 5
dogs contained some individual biopsy specimens with
histopathologic evidence of mild enteritis.
Based on Fleiss kappa statistics evaluation, the inte-
robserver agreement within expert and trainee groups
improved among experts from trial 1 kappa < 0.01
(slight agreement), P > .05, to trial 2 kappa = 0.2 (fair
agreement), P > .05 and among trainees, from trial 1
kappa = 0.02 (slight agreement), P > .05 to trial 2
kappa = 0.2 (fair agreement), P < .05. By the Glimmix
procedure, showing comparison within the groups,
there was a signiﬁcant (P < .01) improvement of 17%
in the trainee endoscopists lesion assessment scores
from trial 1 to trial 2. The expert endoscopists showed
no statistical signiﬁcant improvement between trial 1
and trial 2 (P = .19), although there was an 8%
improvement. Regression analysis showed a signiﬁcant
(P < .01) diﬀerence among operator groups regarding
trial 1 lesion assessment. Repeat duodenal image eval-
uation aided by use of a visual template (trial 2)
improved the overall scores of trainee endoscopists to
near that of expert endoscopists (P = .06).
Table 1. Description of endoscopic variables used in
the study.
Endoscopic Criteria for Duodenal Mucosal Assessment
Hyperemia Gradations of mucosal redness (pale ? red)
Friability Mucosal bleeding on contact with endoscope or
biopsy forceps
Granularity Alteration in the texture of the mucosal surface
Erosions Superﬁcial linear mucosal defect(s) with
hemorrhage
Lymphatic
dilatation
Multifocal to diﬀuse white foci within the mucosa
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Discussion
The results of this study indicate that operator expe-
rience matters when making endoscopic mucosal
assessments. Operator experience can be gained from
performing numerous endoscopic procedures, and the
provision of a written/pictorial template to aide identi-
ﬁcation of mucosal lesions, or both.
Gastrointestinal endoscopy is an important tool in
the diagnosis of IBD in dogs. Gastroscopy, enteros-
copy, and colonoscopy are of value in the assessment
of speciﬁc organ involvement in IBD and to diﬀerenti-
ate IBD from other causes of chronic enteropathy.
Recent advances in patient preparation and instrumen-
tation,15,17,18 mucosal examination techniques,14,19 and
the development of forceps biopsy standards19–21 have
made GI endoscopy the preferred method for diagno-
sis of small and large intestinal inﬂammation.
Inﬂammatory bowel disease in dogs is often charac-
terized by a relapsing and remitting clinical course.
Determination of inﬂammatory activity is important
for assessing disease severity and for potentially tailor-
ing treatment. Diﬀerent indices for assessment of dis-
ease activity have been proposed. Clinical indices
utilize scoring systems derived from GI signs alone
(CIBDAI)2 or in combination with laboratory testing
(CCECAI)1 to quantify intestinal activity. Noninvasive
serologic markers including perinuclear antineutrophil
cytoplasmic antibodies (pANCA)22–24 and C-reactive
protein2,3,25 provide only indirect assessment of disease
activity. Histopathologic examination, while required
for diagnosis of IBD, is hindered by poorly standard-
ized grading criteria and disagreement among patholo-
gists in deﬁning mucosal inﬂammation.26,27
As endoscopy provides immediate and direct assess-
ment of intestinal mucosal damage, endoscopic ﬁnd-
ings might be used to measure inﬂammatory activity.
Several endoscopic activity indices for CD5,6 and
UC7–10 are in use. Salient lesions of IBD in humans
(ie, CD and UC) range from erythema, loss of vascu-
larity, friability, and granularity of the mucosa to ero-
sions/ulceration. Similar endoscopic indices have been
used in IBD in dogs including erythema, friability, ero-
sions/ulceration, cobble-stone appearance (granularity),
white speckling on the surface, and diﬃculty in insuf-
ﬂating (stenosis).1,11,12 Endoscopic and histopathologic
evaluations of the GI tract in dogs and cats reveal that
between 48 and 83% of animals having abnormal duo-
denal endoscopic examination results will have histo-
pathologic lesions.4 Clinical trials utilizing endoscopic
scoring for dogs with IBD are limited and have pro-
vided conﬂicting results on the utility of endoscopic
scoring as a measure of disease activity.1,11 A reason
for this discrepancy could be interobserver variation in
identifying endoscopic abnormalities based on opera-
tor experience and the lack of systematic endoscopic
assessment.
This study investigated interobserver agreement in
the assessment of endoscopic activity in dogs with IBD
using deﬁned descriptors of mucosal appearance. Both
written descriptions and a visual template of mucosal
lesions were used to assess the role of operator experi-
ence in deﬁning duodenal appearance in dogs. Our
results indicated that there was slight to fair interob-
server group agreement in lesion identiﬁcation in
expert and trainee endoscopists for either trial 1 or
trial 2. However, there was signiﬁcant interobserver
diﬀerence in lesion assessment when still images of
A B C D
E F G H
I J K L
Fig 1. Representative still images used in the test template. These images demonstrate the endoscopic appearance of normal mucosa
(A,B); hyperemia (C,D); friability (E,F); lymphatic dilatation (G,H); increased granularity (I,J); and erosions (K,L).
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IBD were evaluated by the 3 experienced versus 5 trai-
nee endoscopists in trial 1. Analysis of interobserver
agreement showed a signiﬁcant diﬀerence among oper-
ator groups regarding lesion assessment with expert
endoscopists having less chance of disagreement
regarding the identiﬁcation of endoscopic abnormali-
ties. This observation of better interobserver agreement
of experienced versus trainee endoscopists emphasizes
the value of operator experience in companion animal
GI endoscopy4 and is similar to results in humans with
IBD.9,28
The association between endoscopic scores of the
duodenum and colon with other inﬂammatory indices
(ie, clinical activity [CIBDAI] and histopathology) as
partial assessment of long-term outcome in dogs with
chronic enteropathies has previously been evaluated.1
The numerical endoscopic scores (range 0–3; normal to
severe mucosal inﬂammation) were assigned by 1 of 2
operators using mucosal assessment criteria of ery-
thema, friability, white speckling, granularity, and
luminal stenosis.1 No correlation was found between
endoscopy scores and histology scores pre- versus post-
treatment; however, an endoscopy score of 3 in the
duodenum, indicative of severe inﬂammation, was sig-
niﬁcantly associated with negative outcome.1 In a sepa-
rate study, Garcia-Sancho et al. performed endoscopic
examination in 16 dogs diagnosed with lymphocytic-
plasmacytic enteritis and evaluated gastric/duodenal
lesions of mucosal erythema, granularity, friability,
erosions, and luminal distension before and after IBD
treatment.11 While the number and relative experience
of endoscopists were not noted in this report, these
investigators showed signiﬁcant diﬀerences between
before and after treatment of macroscopic endoscopic
lesions in the stomach and duodenum.
Our choice of endoscopic mucosal characteristics to
evaluate was based on the personal experiences of AEJ
in performance of duodenoscopic procedures over
30 years. Observer variation for graded characteristics
(ie, mucosal hyperemia—is it pale, pink, or red?) is
quite high, whereas that for discontinuous variables
(ie, presence or absence of erosions) is generally low.8
More importantly, operator experience plays an impor-
tant role in endoscopic assessment with trainee endos-
copists more likely to miss mucosal lesions or
misinterpret normal versus abnormal mucosa. The
results of this study conﬁrm these previous anecdotal
observations. While hyperemia and luminal distensibil-
ity have been used in previous endoscopic indices for
dogs, we have not found them useful in the past or in
this study.1,11
The use of the Fleiss Kappa coeﬃcients was calcu-
lated to assess agreement among multiple observers
versus Cohen’s kappa which only compares interob-
server agreement between 2 observers. Although the
kappa scores within the expert and trainee groups for
trial 1 showed only slight agreement, they both
improved to fair agreement for both operator groups
in trial 2. The P value for the experts in both trials
were greater than .05 and could have been because of
lack of power.
There were several potential limitations of our
study. First, we utilized a single center for our study
and focused only on duodenal endoscopic assessment
of dogs with IBD. Whether the same results for inte-
robserver variability across diﬀerent study centers,
endoscopic interpretation by nonspecialist clinicians,
or evaluation of other alimentary tract organs in dogs
having diﬀerent diseases might yield similar results was
not assessed. Second, we used still images of endo-
scopic lesions versus video streams to evaluate varia-
tion among operator cohorts. Our rationale was that
still images in texts or continuing education events are
routinely utilized for endoscopic training purposes. In
addition, a manageable number of still images could
be more easily evaluated twice by the same clinicians
in this study which assured good compliance. In
humans, accurate assessment of UC endoscopic activ-
ity can be achieved from archived still images.9 Lastly,
one could argue that the modest improvement in
endoscopy scores posttemplate (trial 2) was inﬂuenced
by the designation of novice versus experienced endos-
copists based on the advanced training status and
duration of active clinical GI endoscopic procedure
experience of individual operators. In this regard, it is
possible that outliers in either group (ie, a novice en-
doscopist having greater expertise in recognition of
mucosal appearances, and an experienced endoscopist
having lesser expertise in recognition of mucosal
abnormalities, or both) may have falsely reduced inte-
robserver agreement within an operator group. It is
also possible that gross mucosal observations alone are
insuﬃcient for deﬁning mucosal appearance of IBD in
dogs but aided by considering other indices as well,
including clinical scores, serologic markers, and the
severity of inﬂammation.1,2,22–26
In summary, a simple compilation of the variable
mucosal appearances in the duodenum of dogs with
IBD is described. According to the results from this
study, accurate assessment of IBD activity from duo-
denal endoscopic appearance beneﬁtted from operator
experience. Acceptable agreement rates might be
obtained by endoscopists under training using well-
deﬁned endoscopic appearances.
Footnotes
a Olympus Optical, Tokyo, Japan
b Research report randomizer http://www.randomizer.org
c Powerpoint, Microsoft, Redmond, WA
d Excel, Microsoft, Redmond, WA
e R Core Team, Vienna, Austria
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